
https://www.science.org/content/blog-post/bread-rolls-synthesis
# The Bread Rolls of Synthesis (February 2014)

## 1. SUMMARY
The article uses a quote from Fritz Haber describing his doctoral thesis as "miserable" work - creating new substances "like baker's bread rolls" with mostly negative results. The author, a medicinal chemist, extends this metaphor to distinguish between two types of chemical synthesis: (1) "bread roll" syntheses of random compounds with no particular purpose or known activity, published in low-tier journals as incremental reference data, and (2) purpose-driven synthesis where medicinal chemists rapidly generate analogs ("bricks") to test against a biological target and build toward meaningful therapeutic activity.

The key distinction is intentionality - while both may produce many compounds, medicinal chemistry synthesis serves the specific goal of discovering compounds with desired biological activity, even if most analogs fail. The author acknowledges that filling compound archives with tested but inactive compounds still has value for drug discovery programs, unlike the academic practice of publishing random derivatives of obscure heterocyclic cores merely for the sake of publication.

## 2. HISTORY
In the decade following this article, several developments reshaped synthesis practices in drug discovery:

**Academic Publishing Trends**: The rise of predatory journals and continued pressure for publication volume sustained the "bread roll" phenomenon this article criticized. However, computational chemistry and virtual screening increasingly allowed researchers to more strategically select targets.

**Automation and High-Throughput Synthesis**: Pharmaceutical companies expanded automated synthesis platforms (2015-2020), enabling rapid generation of thousands of analogs while reducing laborious manual synthesis. Companies like GSK, Pfizer, and Novartis invested heavily in this area.

**Data-Driven Drug Design**: The 2010s saw growth in computational approaches, machine learning models for drug discovery, and publicly accessible chemical databases. Initiatives like ChEMBL and PubChem accumulated vast structure-activity data, flipping the value proposition - the marginal utility of additional tested compounds increased.

**FDA Drug Approvals**: Between 2014-2022, the FDA approved ~450 new drugs. Many originated from the "brick-making" approach described - extensive analog synthesis followed by iterative testing and optimization, particularly for kinase inhibitors, protease inhibitors, and immunomodulators.

## 3. PREDICTIONS
The article made more observations than explicit predictions, but several themes emerged:

- **The lower tier papers would continue**: ✓ Correct - despite criticism, academic production of random derivative chemistry papers persisted.

- **Medicinal chemistry would require extensive analog synthesis**: ✓ Correct - the brick-by-brick iterative approach remains standard practice in drug discovery.

- **Marginal utility of random compounds is low**: ⚠️ Partial - while single-point modifications lack immediate value, aggregated structure-activity data gained importance for machine learning and predictive modeling.

- **Large compound collections are useful despite low hit rates**: ✓ Correct - pharmaceutical archives grew, companies like Enamine offered over 5 million screening compounds by 2020, and large libraries proved valuable for AI-driven discovery.

- **Activity-focused synthesis is the goal**: ✓ Correct - the decade that followed emphasized phenotypic screening, target-based approaches, and structure-guided drug design where compounds are specifically designed for biological relevance.

## 4. INTEREST
Rating: **8/10**

This isn't the most interesting article because it describes routine drug discovery. It ranks high because it insightfully crystallizes the tension between purposeless synthesis and purposeful medicinal chemistry, connecting Fritz Haber's century-old reflection to the realities faced by today's scientists. The metaphor proved durable and useful for discussing what gives chemical research value.


----
_model_params = {'model': 'nex-agi/deepseek-v3.1-nex-n1:free', 'input': '20140212-bread-rolls-synthesis.txt', 'reasoning': {'effort': 'high'}, 'text': {'verbosity': 'medium'}, 'prompt-template': 'prompt-template-2'}_